Materialise NV Earnings Call Highlights Margin Upswing

Materialise NV ((MTLS)) has held its Q1 earnings call. Read on for the main highlights of the call.

Materialise NV’s latest earnings call painted a cautiously upbeat picture, as stable revenue combined with expanding margins and stronger cash generation offset lingering pockets of weakness. Management highlighted meaningful gains in profitability, growing momentum in Medical and Software, and a solid balance sheet, even as FX headwinds, softer Manufacturing demand, and divestments weighed on the top line.

Stable Revenue with Margin Expansion

Materialise kept Q1 revenue flat year on year at EUR 66.3 million, a notable feat given FX pressure and softer end markets. More importantly for investors, gross profit rose to EUR 37.9 million and gross margin expanded to 57.2%, signaling better pricing, mix, and efficiency rather than pure volume growth.

Material Improvement in Profitability

The company turned incremental revenue resilience into significantly higher profits, with adjusted EBITDA jumping above 30% year on year to EUR 8.0 million and margins improving to 12.1%. Adjusted EBIT climbed to EUR 2.5 million and net profit reached EUR 1.8 million, underscoring tighter cost control and improved operating leverage.

Medical Segment Growth and Product Launches

Medical remained the growth engine, with revenue up 7% to EUR 33.2 million, or roughly 10% on a constant currency basis, and Medical Devices advancing about 11%. New offerings such as custom PEEK cranio‑maxillofacial implants and OrthoView 3D Hip broadened CT‑based planning and strengthened Materialise’s integrated medical ecosystem.

Software Business Progress and Recurring Revenue

Software revenue slipped 1% to EUR 9.6 million on a reported basis but gained about 5% in constant currency, showing underlying resilience during the cloud transition. Recurring revenue expanded to 83% of software sales and adjusted EBITDA nearly doubled to EUR 1.1 million, highlighting improving profitability as subscriptions scale.

Strategic Partnerships and Product Distribution Wins

Materialise deepened its relationship with HP, as Magics Print for HP will ship with the new MJF 1200 printer, opening doors to broader lower and mid‑range users. The company also advanced CO‑AM Professional, with seven customers entering early access and presales underway ahead of a planned broader launch in mid‑2026.

Manufacturing Sequential Improvement in Strategic Areas

Manufacturing revenue fell 8% year on year to EUR 23.5 million, yet showed sequential improvement after three weaker quarters, hinting at stabilization. Growth in strategic niches such as aerospace, defense, and semiconductors, coupled with a return to positive adjusted EBITDA of EUR 0.3 million, suggests the segment is slowly turning a corner.

Strong Cash Position and Positive Free Cash Flow

The balance sheet remains a key support for the equity story, with a cash reserve of EUR 133 million and gross debt trimmed to EUR 60.1 million, yielding net cash of EUR 72.8 million. Operating cash flow of about EUR 7 million and disciplined capex of EUR 1.5 million led to EUR 5.7 million of free cash flow, giving the group financial flexibility.

Sustainability and Reporting Milestones

Beyond the numbers, Materialise delivered on governance and sustainability by issuing its first annual report post‑listing and completing CSRD reporting. The company exceeded greenhouse gas reduction goals, cutting over 1,500 tons of CO2 in a rolling two‑year period and leveraging a solar park that now provides more than 40% of its headquarters’ electricity.

Strategic Portfolio Repositioning

Management continued to streamline the portfolio, transferring RapidFit and the eyewear business to their respective management teams while keeping a minority stake in eyewear. The move is intended to refocus capital and leadership on core segments, while allowing the spun‑out operations to pursue growth more nimbly and improve group‑level profitability.

Foreign Exchange Headwinds

Currency movements, particularly a weaker U.S. dollar, weighed noticeably on reported figures, especially in Medical and Software. Management noted that on a constant currency basis, both segments would have shown stronger growth, emphasizing that FX volatility, rather than operational weakness, dampened the headline numbers.

Manufacturing Decline and Weak Prototyping Demand

The 8% year‑on‑year decline in Manufacturing was largely tied to macro softness and subdued prototyping activity, especially in Europe’s automotive sector. This demand drag underscores the cyclical exposure of parts of the business and explains management’s push toward higher‑value, less cyclical applications.

Reported Software Revenue Slightly Down

While software’s constant currency growth was solid, the reported 1% decline to EUR 9.6 million highlighted the near‑term growing pains of transitioning to cloud and subscription. Management acknowledged that FX effects and the mix shift can blur short‑term trends even as recurring revenue and profitability move in the right direction.

Regional and End‑Market Softness

End markets in Europe remain under pressure, with automotive customers particularly cautious, which feeds through into lower prototyping volumes. In contrast, the U.S. shows more signs of recovery, though budget cuts in academic and research institutions are weighing on a smaller part of the customer base.

Top‑Line Pressure from Divestments

The planned transfers of RapidFit and eyewear will trim Manufacturing revenue and add further drag to reported growth in the near term. Management argued that the revenue gap should be absorbed over time and that the moves will ultimately strengthen profitability and strategic focus, a trade‑off investors will watch closely.

Ongoing Macroeconomic and Geopolitical Uncertainty

Management cautioned that macroeconomic and geopolitical uncertainty is likely to persist through 2026, clouding demand visibility and adding FX risk. Nonetheless, they believe the company’s diversified end markets and strong financial position should help cushion shocks and support continued investment.

Guidance and Outlook

Despite divestments and a murky macro backdrop, Materialise reaffirmed its full‑year 2026 outlook for revenue between EUR 273 million and EUR 283 million and adjusted EBIT of EUR 10 million to EUR 12 million. The confident stance rests on Q1 metrics including solid margins, EUR 72.8 million net cash, substantial deferred revenue, and clear expectations that Manufacturing EBITDA will remain positive in 2026.

Materialise’s earnings call ultimately blended cautious realism with tangible progress, as profitability, Medical and Software momentum, and a strong balance sheet countered FX drag and cyclical weakness in Manufacturing. For investors, the key takeaways are stable revenue, rising margins, disciplined capital allocation, and management’s visible confidence in meeting its medium‑term targets despite an uncertain global backdrop.